Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Non Operating Income: 2013-2025

Historic Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 13 years, with Apr 2025 value amounting to $7.9 million.

  • KalVista Pharmaceuticals' Non Operating Income fell 6.88% to $3.5 million in Q2 2025 from the same period last year, while for Apr 2025 it was $15.2 million, marking a year-over-year increase of 12.00%. This contributed to the annual value of $7.9 million for FY2025, which is 42.45% down from last year.
  • As of FY2025, KalVista Pharmaceuticals' Non Operating Income stood at $7.9 million, which was down 42.45% from $13.8 million recorded in FY2024.
  • In the past 5 years, KalVista Pharmaceuticals' Non Operating Income registered a high of $18.0 million during FY2023, and its lowest value of $7.9 million during FY2025.
  • Its 3-year average for Non Operating Income is $13.2 million, with a median of $13.8 million in 2024.
  • In the last 5 years, KalVista Pharmaceuticals' Non Operating Income increased by 26.05% in 2022 and then plummeted by 42.45% in 2025.
  • KalVista Pharmaceuticals' Non Operating Income (Yearly) stood at $11.7 million in 2021, then rose by 26.05% to $14.7 million in 2022, then climbed by 22.03% to $18.0 million in 2023, then declined by 23.17% to $13.8 million in 2024, then slumped by 42.45% to $7.9 million in 2025.